Evidence shows that BRAF inhibitors induce reactive oxygen species (ROS) levels in melanoma cells through Peroxisome proliferator-activated receptor gamma coactivator 1 (PGC1α)-induced mitochondria biogenesis [5]. Here, BRAF is linked to melanoma.